Ny, NYCIK 20031471 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
14 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Pfizer Inc | 2.04M | $50.85M | 16.4% | +2.04M | New Position |
| 2 | Regeneron Pharmaceuticals | 52.4K | $40.46M | 13.1% | +52.4K | New Position |
| 3 | Biontech Se | 371.2K | $35.34M | 11.4% | +371.2K | New Position |
| 4 |
| 840.6K |
| $32.48M |
| 10.5% |
| +840.6K |
| New Position |
| 5 | Argenx Se | 35.7K | $30.01M | 9.7% | +35.7K | New Position |
| 6 | Legend Biotech Corp | 1.06M | $22.97M | 7.4% | +1.06M | New Position |
| 7 | Roivant Sciences Ltd | 1.03M | $22.31M | 7.2% | +1.03M | New Position |
| 8 | Ionis Pharmaceuticals Inc | 238.5K | $18.87M | 6.1% | +238.5K | New Position |
| 9 | Natera Inc | 78.7K | $18.02M | 5.8% | +78.7K | New Position |
| 10 | Eli Lilly & Co | 8.3K | $8.93M | 2.9% | +8.3K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio